Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension

Hypertension

Volumn 54, Issue 6, 2009, Pages 1401-1407

  Falcao, Stéphanie ^a,b,c   Stoyanova, Ekatherina ^c   Cloutier, Guy ^a,d,f   Maurice, Roch L ^a,d,f   Gutkowska, Jolanta ^b,e   Lavoie, Julie L ^b,e  

^a Laboratory of Biorheology and Medical Ultrasonics   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Radiology   (Switzerland)

^d Department of Nuclear Medicine ^*

^e Institute of Biomedical Engineering   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiac hypertrophy; Hypertension; Mouse model; Preeclampsia; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CHRONIC DISEASE; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HEART FUNCTION; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MOLECULAR MECHANICS; MOTHER; MOUSE; NONHUMAN; PATHOLOGY; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; PUP (RODENT); REAL TIME POLYMERASE CHAIN REACTION; REPRODUCTION; RISK FACTOR; TELEMETRY; TRANSGENIC MOUSE; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; C57BL MOUSE; CARDIOMEGALY; DISEASE MODEL; GENETICS; HUMAN; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINOGEN; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; CARDIOMEGALY; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERTENSION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 73349101548     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.137356     Document Type: Article

References (45)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365: 785-799
2. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23:359-372
3. Brown MA, Lindheimer MD, de SM, Van AA, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX-XIV
4. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 2-nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ. 1997;157:907-919 (Pubitemid 27460108)
5. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet. 2003;64:96-103
6. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 2008;453:1117-1121
7. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007;50: 1142-1147
8. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol. 2005;288:F614-F625
9. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689
10. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952
11. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-2387
12. Rothermel A, Kurz R, Ruffer M, Weigel W, Jahnke HG, Sedello AK, Stepan H, Faber R, Schulze-Forster K, Robitzki AA. Cells on a chip-the use of electric properties for highly sensitive monitoring of blood-derived factors involved in angiotensin II type 1 receptor signalling. Cell Physiol Biochem. 2005;16:51-58
13. Dechend R, Muller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Activating auto-antibodies against the AT1 receptor in pre-eclampsia. Autoimmun Rev. 2005;4:61-65
14. Cooper AC, Robinson G, Vinson GP, Cheung WT, Broughton PF. The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy. Placenta. 1999;20:467-474
15. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274:995-998
16. Bohlender J, Ganten D, Luft FC. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol. 2000;11:2056-2061 (Pubitemid 30812703)
17. Merrill DC, Thompson MW, Carney C, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047-1055
18. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo M-S, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K. Chimeric renin-angio-tensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993;268:11617-11621
19. Sugiyama F. Development of genetically engineered mice with hypertension and hypotension. Exp Anim. 1997;46:171-182
20. Ganten D, Wagner J, Zeh K, Koeller M, Bader M, Michel JB, Paul M, Zimmermann F, Ruf P, Hilgenfeld U, Ganten U, Kaling M, Bachmann S, Mullins JJ, Murakami K. Species-specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1992;89:7806-7810
21. Lavoie JL, Bianco RA, Sakai K, Keen HL, Ryan MJ, Sigmund CD. Transgenic mice for studies of the renin-angiotensin system in hypertension. Acta Physiol Scand. 2004;181:571-577
22. Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis. 2007;14:178-190
23. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA, Gross KW. Regulated tissue-and cell-specific expression of the human renin gene in transgenic mice. Circ Res. 1992;70:1070-1079
24. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502
25. Falcao S, Solomon C, Monat C, Berube J, Gutkowska J, Lavoie JL. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice. Am J Physiol Heart Circ Physiol. 2009;296: H119-H126
26. Falcao S, Bisotto S, Gutkowska J, Lavoie JL. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. Am J Obstet Gynecol. 2009;200:198.e1-198.e5
27. Stoyanova E, Trudel M, Felfly H, Garcia D, Cloutier G. Characterization of circulatory disorders in beta-thalassemic mice by noninvasive ultrasound biomicroscopy. Physiol Genomics. 2007;29:84-90
28. Buitrago M, Lorenz K, Maass AH, Oberdorf-Maass S, Keller U, Schmit-teckert EM, Ivashchenko Y, Lohse MJ, Engelhardt S. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med. 2005;11:837-844
29. Iso T, Arai M, Wada A, Kogure K, Suzuki T, Nagai R. Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natri-uretic peptide expression. Am J Physiol. 1997;273:H113-H118
30. Jankowski M, Wang D, Mukaddam-Daher S, Gutkowska J. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle. J Endocrinol. 2005;184:209-217
31. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75:1-8
32. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54:2056-2063
33. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22
34. Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. J Perinat Med. 2008;36:38-58
35. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, Genuardi M, Abbate R, Fatini C. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension. 2003; 41:932-937
36. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M. A molecular variant of angioten-sinogen associated with preeclampsia. Nature Genetics. 1993;4:59-61
37. Medica I, Kastrin A, Peterlin B. Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2007;131:115-126 (Pubitemid 46452915)
38. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM. Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol. 2002;283:H1569-H1576
39. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59:61-78
40. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683
41. Baumann MU, Bersinger NA, Surbek DV. Serum markers for predicting pre-eclampsia. Mol Aspects Med. 2007;28:227-244
42. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension. 2004;43: 661-666
43. Eghbali M, Wang Y, Toro L, Stefani E. Heart hypertrophy during pregnancy: a better functioning heart? Trends Cardiovasc Med. 2006;16: 285-291
44. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the patho-genesis of preeclampsia. Pediatr Res. 2005;57:1R-7R
45. Uhler MD, McKnight GS. Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem. 1987; 262:15202-15207